We presented a novel fuzzy multicriteria decision making approach to evaluate and rank organizational resilience factors with respect to user preference orders. Due to vagueness of the decision data, the precise numerical data are inadequate for real-life business situations. Human judgements can be expressed by linguistic expressions which are modeled by fuzzy sets. The complexity of the considered problem calls for analytic methods rather than intuitive decisions. Two fuzzy multi-criteria methods are proposed for solving the treated problem: Fuzzy Analytic Hierarchical Process (FAHP) is applied to determine the relative importance of business processes and the relative importance of organizational resilience factors under each business process, and an extension of the fuzzy Technique for Order Preference by Similarity to Ideal Solution (FTOPSIS) is applied to rank the organizational resilience factors. With respect to complexity and the type of considered management problem, we introduce a modified fuzzy decision matrix. The proposed algorithm has efficiently been applied in the assessment of organizational resilience factors to small and medium enterprises of the process industry.
The simpler oral cavity OAR should be preferred over the mucosal surface OAR for NTCP modelling of severe mucositis. We recommend minimising the volume of mucosa receiving intermediate and high doses, where possible.
Considering the high bleeding risk in patients with ITP and AMI, careful balance between usual anticoagulation and antiplatelet therapy on the one hand, and efforts to raise platelet count on the other hand are needed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.